Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H20O10 |
Molecular Weight | 432.3775 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C2=C(O)C3=C(OC(=CC3=O)C4=CC=C(O)C=C4)C=C2O
InChI
InChIKey=MYXNWGACZJSMBT-VJXVFPJBSA-N
InChI=1S/C21H20O10/c22-7-14-17(26)19(28)20(29)21(31-14)16-11(25)6-13-15(18(16)27)10(24)5-12(30-13)8-1-3-9(23)4-2-8/h1-6,14,17,19-23,25-29H,7H2/t14-,17-,19+,20-,21+/m1/s1
Molecular Formula | C21H20O10 |
Molecular Weight | 432.3775 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Isovitexin (apigenin-6-C-glucoside), an isomer of vitexin, is found in plants such as pigeon pea, Passiflora, bamboo, mimosa, wheat leaves, rice hull of Oryza sativa and others. Isovitexin is poorly absorbed in the gastrointestinal tract. The highest level of intravenously administrated isovitexin was examined in kidney, liver, lung, and lowest in the brain. Isovitexin helps to stimulate apoptotic cell death and autophagy of various cancer cells through the upstream regulation of Bax, PARP, p-JNK, and MAPK and the downstream regulation of the caspases Bcl-2 and ERK1/2. Isovitexin has been proved to have various activities, such as anti-oxidant, anti-inflammatory, anti-Alzheimer's disease and others.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27693342
Curator's Comment: Known to be CNS penetrant in rats. Human data not available.
Lowest level
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: WP408 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27693342 |
|||
Target ID: WP254 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28891090 |
|||
Target ID: CHEMBL1900 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24291393 |
0.13 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Preventing | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Phenolic constituents of Phenax angustifolius. | 2001 Jan |
|
Characterization of the polyphenolic composition of purple loosestrife (Lythrum salicaria). | 2001 Jan-Feb |
|
Acylated flavone C-glycosides from Cucumis sativus. | 2001 Sep |
|
Phenolic constituents and antioxidant properties of Xanthosoma violaceum leaves. | 2003 Oct 22 |
|
Distinction of the C-glycosylflavone isomer pairs orientin/isoorientin and vitexin/isovitexin using HPLC-MS exact mass measurement and in-source CID. | 2005 Sep-Oct |
|
[Studies on chemical constituents from stellaria media. I]. | 2007 Jun |
|
Aromatic diglycosides from Cladogynos orientalis. | 2007 Mar |
|
Flavonoids from Acacia pennata and their cyclooxygenase (COX-1 and COX-2) inhibitory activities. | 2007 Sep |
|
Isovitexin-2'-O-beta-[6-O-E-p-coumaroylglucopyranoside] from UV-B irradiated leaves of rice, Oryza sativa L. inhibits fertility of Helicoverpa armigera. | 2007 Sep-Oct |
|
Determination of vitexin and isovitexin in pigeonpea using ultrasonic extraction followed by LC-MS. | 2008 Feb |
|
Phytochemical and antifungal studies on Terminalia mollis and Terminalia brachystemma. | 2009 Sep |
|
Potential insulin secretagogue effects of isovitexin and swertisin isolated from Wilbrandia ebracteata roots in non-diabetic rats. | 2010 Dec |
|
Chemical composition of the SFE-CO extracts from Cajanus cajan (L.) Huth and their antimicrobial activity in vitro and in vivo. | 2010 Dec 1 |
|
The constituents of Urtica cannabina used in Uighur medicine. | 2010 May |
|
Topical and systemic anti-inflammatory effects of Echinodorus macrophyllus (Kunth) Micheli (Alismataceae). | 2010 Oct |
|
Extracts from the Mongolian traditional medicinal plants Dianthus versicolorFisch. and Lilium pumilum Delile stimulate bile flow in an isolated perfused rat liver model. | 2010 Oct 5 |
|
Comparative study of the flavonoids of some Verbena species cultivated in Egypt by using high-performance liquid chromatography coupled with ultraviolet spectroscopy and atmospheric pressure chemical ionization mass spectrometry. | 2010 Oct 8 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25096710
Rat: 0.1 or 0.25 mg/kg
Route of Administration:
Intragastric
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15965085
Isovitexin inhibited the release of TNF-alpha, a proinflammatory cytokine, upon LPS activation of RAW 264.7 macrophages with a 50% inhibitory concentration (IC50) of 78.6 uM. Isovitexin markedly reduced LPS-stimulated PGE2 production in a concentration-dependent manner, with an IC50 of 80.0 uM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:56:09 GMT 2025
by
admin
on
Mon Mar 31 22:56:09 GMT 2025
|
Record UNII |
KTQ9R9MS0Q
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
4451 (Number of products:1)
Created by
admin on Mon Mar 31 22:56:09 GMT 2025 , Edited by admin on Mon Mar 31 22:56:09 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
18330
Created by
admin on Mon Mar 31 22:56:09 GMT 2025 , Edited by admin on Mon Mar 31 22:56:09 GMT 2025
|
PRIMARY | |||
|
KTQ9R9MS0Q
Created by
admin on Mon Mar 31 22:56:09 GMT 2025 , Edited by admin on Mon Mar 31 22:56:09 GMT 2025
|
PRIMARY | |||
|
DTXSID60952152
Created by
admin on Mon Mar 31 22:56:09 GMT 2025 , Edited by admin on Mon Mar 31 22:56:09 GMT 2025
|
PRIMARY | |||
|
Isovitexin
Created by
admin on Mon Mar 31 22:56:09 GMT 2025 , Edited by admin on Mon Mar 31 22:56:09 GMT 2025
|
PRIMARY | |||
|
162350
Created by
admin on Mon Mar 31 22:56:09 GMT 2025 , Edited by admin on Mon Mar 31 22:56:09 GMT 2025
|
PRIMARY | |||
|
38953-85-4
Created by
admin on Mon Mar 31 22:56:09 GMT 2025 , Edited by admin on Mon Mar 31 22:56:09 GMT 2025
|
PRIMARY | |||
|
58447
Created by
admin on Mon Mar 31 22:56:09 GMT 2025 , Edited by admin on Mon Mar 31 22:56:09 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
ORAC value expressed as umol TE/g for this compound is 22404.5 +/- 1322.1.
ORAC is a chemical antioxidant assay that is based on the inhibition of the peroxyl-radical induced oxidation initiated by thermal decomposition of AAPH.
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |